Sandu Pharmaceuticals Board Meeting on Nov 14 to Approve Q2 Results

Sandu Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 14, 2026, at 4:00 p.m. at its corporate office in Mumbai. The primary agenda item is to consider and approve the standalone unaudited financial results for the quarter ended September 30, 2026. Additionally, the board will discuss any other matters with the permission of the Chair. In line with SEBI regulations, the trading window for company directors and designated employees will remain closed from October 1, 2026, until 48 hours after the financial results are publicly announced.